Voyager Therapeutics, Inc. Common Stock (VYGR) is a publicly traded Healthcare sector company. As of July 13, 2026, VYGR trades at $3.31 with a market cap of $207.85M and a P/E ratio of -1.73. VYGR moved -4.94% today. Year to date, VYGR is -12.69%; over the trailing twelve months it is -3.10%. Its 52-week range spans $2.65 to $7.44. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces VYGR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks VYGR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.31 |
| Market Cap | $207.85M |
| P/E Ratio | -1.73 |
| EPS | $-2.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.44 |
| 52-Week Low | $2.65 |
| Volume | 442.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $40.37M |
| Net Income | $-119.72M |
| Gross Margin | 0.00% |
6 analysts cover VYGR: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.